Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin J Sutherland

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
The Lancet. Infectious Diseases|November 3, 2022
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance studyKhalid B Beshir, Julian Muwanguzi, Johanna Nader, et al.
Journal of Medicinal Chemistry|August 12, 2024
Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4Trent D Ashton, Petar P S Calic, Madeline G Dans, et al.
Plos Medicine|October 19, 2020
The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysisAndria Mousa, Abdullah Al-Taiar, Nicholas M Anstey, et al.
Nature Communications|September 30, 2024
Author Correction: Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1Madeline G Dans, Coralie Boulet, Gabrielle M Watson, et al.
Nature Communications|June 18, 2024
Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1Madeline G Dans, Coralie Boulet, Gabrielle M Watson, et al.
Nature Communications|February 10, 2018
Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunityWill J R Stone, Joseph J Campo, André Lin Ouédraogo, et al.
Nature Communications|April 13, 2018
Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunityWill J R Stone, Joseph J Campo, André Lin Ouédraogo, et al.
Journal of Medicinal Chemistry|April 14, 2025
Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4Jon Kyle Awalt, Zi Kang Ooi, Trent D Ashton, et al.
Nature Communications|February 22, 2014
African origin of the malaria parasite Plasmodium vivaxWeimin Liu, Yingying Li, Katharina S Shaw, et al.
The American Journal of Tropical Medicine and Hygiene|July 23, 2014
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquineMeera Venkatesan, Nahla B Gadalla, Kasia Stepniewska, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
The Lancet. Infectious Diseases|November 3, 2022
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance studyKhalid B Beshir, Julian Muwanguzi, Johanna Nader, et al.
Journal of Medicinal Chemistry|August 12, 2024
Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4Trent D Ashton, Petar P S Calic, Madeline G Dans, et al.
Plos Medicine|October 19, 2020
The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysisAndria Mousa, Abdullah Al-Taiar, Nicholas M Anstey, et al.
Nature Communications|September 30, 2024
Author Correction: Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1Madeline G Dans, Coralie Boulet, Gabrielle M Watson, et al.
Nature Communications|June 18, 2024
Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1Madeline G Dans, Coralie Boulet, Gabrielle M Watson, et al.
Nature Communications|February 10, 2018
Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunityWill J R Stone, Joseph J Campo, André Lin Ouédraogo, et al.
Nature Communications|April 13, 2018
Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunityWill J R Stone, Joseph J Campo, André Lin Ouédraogo, et al.
Journal of Medicinal Chemistry|April 14, 2025
Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4Jon Kyle Awalt, Zi Kang Ooi, Trent D Ashton, et al.
Nature Communications|February 22, 2014
African origin of the malaria parasite Plasmodium vivaxWeimin Liu, Yingying Li, Katharina S Shaw, et al.
The American Journal of Tropical Medicine and Hygiene|July 23, 2014
Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquineMeera Venkatesan, Nahla B Gadalla, Kasia Stepniewska, et al.
Pageof 20